Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px

News > All

Total search results: 10170 | Ordered by Date (descending)
next pagenext page 1 2 3 4 ... 100 101 102  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Amply Discovery Ltd.. (2/12/24). "Press Release: Amply Discovery Raises £1.4m in Innovate UK Grant Funding to Tackle Complex Diseases". 2024-02-12
Sensorion S.A.. (2/9/24). "Press Release: Sensorion Announces a €50.5 Million Financing with Participation from New and Existing US and European Healthcare Specialist Investors [ not for US, et al.; only for qualified persons]". Montpellier. 2024-02-09
T-Curx GmbH. (2/9/24). "Press Release: T-Curx Extends Its Management Team with Marion Jung, PhD, as Its New Chief Operating Officer". 2024-02-09
BioNTech SE. (2/8/24). "Press Release: BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs". Mainz & London. 2024-02-08
GenSight Biologics S.A.. (2/8/24). "Press Release: GenSight Biologics Announces Completion of a €5 million capital Increase with Sofinnova Partners, Invus, UPMC Enterprises and Heights Capital". Paris. 2024-02-08
Israel Advanced Technology Industries (IATI). (2/8/24). "Press Release: MIXiii Health-Tech.IL Annual Conference to Showcase Resilience and Growth of Israel's Life Sciences Industry Amid War". Herzliya. 2024-02-08
Zetta Genomics Ltd.. (2/8/24). "Press Release: Zetta Genomics Expands Second Seed Funding Round with Additional £1.8 Million". 2024-02-08
VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY. 2024-02-07
Nuclera Ltd.. (2/7/24). "Press Release: Nuclera Partners with Sharp Life Science Advancing Its Digital Microfluidics Capability". 2024-02-07
FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. 2024-02-07
Sablebio Ltd. (Sable Bio). (2/6/24). "Press Release: Sable Bio Raises £1.5m Pre-seed Round to Transform Drug Discovery Safety Assessments". London. 2024-02-06
Silence Therapeutics plc. (2/5/24). "Press Release: Silence Therapeutics Announces Oversubscribed $120 Million Private Placement". London. 2024-02-05
MorphoSys AG. (2/5/24). "Press Release: MorphoSys Enters into Business Combination Agreement to Be Acquired by Novartis for € 2.7 Billion Equity Value. Tafasitamab Sold to Incyte". Planegg. 2024-02-05
Theryq. (2/2/24). "Press Release: Theryq and Gustave Roussy Have Been Selected as Part of the "i-Démo" France 2030 Call for Projects". Rousset. 2024-02-02
NLC Ventures Netherlands B.V.. (2/2/24). "Press Release: NLC Health Ventures and BioScience Valuation (BSV) Announce Strategic Collaboration". Amsterdam. 2024-02-02
Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". 2024-02-01
ITM Isotope Technologies Munich SE. (2/1/24). "Press Release: ITM Obtains Manufacturing License in the U.S.". Garching & Princeton, NJ. 2024-02-01
Praque.bio, z.s.. (2/1/24). "Press Release: Petra Kinzlova Became the New Director of the Prague.bio Cluster". Prague. 2024-02-01
EnteroBiotix Ltd.. (2/1/24). "Press Release: EnteroBiotix Strengthens Its Executive Team, Appoints COO and CFO". Glasgow. 2024-02-01
Silence Therapeutics plc. (1/31/24). "Press Release: Silence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference". London. 2024-01-31
BioNTech SE. (1/31/24). "Press Release: BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305". Mainz & Shanghai. 2024-01-31
Aqemia SAS. (1/30/24). "Press Release: Aqemia Boosts Series A Funding to €60M to Accelerate on its Proprietary Therapeutic Pipeline". Paris. 2024-01-30
Enterprise Therapeutics Ltd.. (1/30/24). "Press Release: Enterprise Therapeutics Closes £26 million ($33.1 million) Series B Follow-on Financing". Brighton. 2024-01-30
ITM Isotope Technologies Munich SE. (1/30/24). "Press Release: ITM and Alpha-9 Oncology Announce Global Supply Agreement to Support Alpha-9’s Clinical Radiopharmaceutical Development Program". Garching & Vancouver, BC. 2024-01-30
BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. 2024-01-30
Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. 2024-01-30
Kadans Science Partner. (1/29/24). "Press Release: Kadans Becomes New Partner for Rheinland-Pfalz Location – Collaboration with Technologiezentrum Mainz". 2024-01-29
Affluent Medical S.A.. (1/29/24). "Press Release: Affluent Medical Closes €3.5 Million Bridge via Capital Iincrease from Key Shareholders [not for US, CA, AU, or JP]". Aix-en-Provence. 2024-01-29
Green Elephant Biotech GmbH. (1/29/24). "Press Release (Blog Post): Product Launch. Green Elephant Biotech Launches the World's First Plant-based 96-well Plate". 2024-01-29
Formycon AG. (1/29/24). "Press Release: Gedeon Richter Becomes Strategic Investor of Formycon via Equity Investment". Munich & Budapest. 2024-01-29
Hookipa Pharma Inc.. (1/29/24). "Press Release: Hookipa Pharma Provides Update on Business Priorities and Oncology Partnership Programs". New York, NY & Vienna. 2024-01-29
SGS S.A.. (1/26/24). "Press Release: Géraldine Picaud to Succeed Frankie Ng as Chief Executive Officer". 2024-01-26
Pierre Fabre. (1/26/24). "Press Release: Eau Thermale Avène Hits a Billion Euros in Turnover, and Strengthens Its Medical Positioning". Toulouse. 2024-01-26
SGS S.A.. (1/26/24). "Press Release: SGS 2023 Full Year Results and Strategic Update". 2024-01-26
InflaRx N.V.. (1/25/24). "Press Release: InflaRx Announces Initiation of Its Commitment Program for GOHIBIC (vilobelimab) to Help Broaden Access for Eligible Patients". Ann Arbor, MI. 2024-01-25
Repare Therapeutics Inc.. (1/25/24). "Press Release: Repare Therapeutics Announces Achievement of $40 Million Roche Clinical Milestone Payment". Cambridge, MA & Montréal. 2024-01-25
Bruker Corporation. (1/25/24). "Press Release: Bruker Announces Agreement to Acquire Chemspeed". Basel. 2024-01-25
BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. 2024-01-24
IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. 2024-01-24
BioLizard N.V.. (1/23/24). "Press Release: BioLizard Opens Office in Switzerland – AI-powered Digital Transformation of Life Sciences at Biopôle in Lausanne". Lausanne & Ghent. 2024-01-23
Bruker Corporation. (1/23/24). "Press Release: Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts". Zürich & Newton, MA. 2024-01-23
Sano Genetics Ltd.. (1/22/24). "Press Release: Sano Genetics Raises $11.4 Million Led by Plural to Power Precision Medicine Revolution with Seamless Trials". Cambridge. 2024-01-22
BioNTech SE. (1/22/24). "Press Release: BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer". Mainz & Shanghai. 2024-01-22
Transgene S.A.. (1/22/24). "Press Release: Transgene Further Strengthens Management Team with Appointment of James Wentworth as Chief Business Officer". Strasbourg. 2024-01-22
ReiThera S.r.l.. (1/22/24). "Press Release: ReiThera Srl, the Ragon Institute and IAVI Announce Collaboration to Advance Highly Networked T Cell HIV Vaccine Candidate Towards Phase I Clinical Evaluation". Rome & Cambridge, MA. 2024-01-22
Sensorion S.A.. (1/19/24). "Press Release: Sensorion Announces Approval to Initiate Lead Gene Therapy Candidate SENS-501 (OTOF-GT) into a Phase 1/2 Clinical Trial in some European Countries". Montpellier. 2024-01-19
CureVac N.V.. (1/17/24). "Press Release: CureVac CEO Alexander Zehnder Acquires Common Shares of Company Stock". Tübingen & Boston, MA. 2024-01-17
ITM Isotope Technologies Munich SE. (1/16/24). "Press Release: ITM Appoints Dr. Mark Harfensteller as Member of Its Executive Board". Garching. 2024-01-16
Disco Pharmaceuticals GmbH. (1/16/24). "Press Release: Disco Pharmaceuticals Launches as the Surfaceome Company with EUR 20 Million in Seed Financing". Cologne & Zurich. 2024-01-16
Stalicla S.A.. (1/16/24). "Press Release: Stalicla Secures $17.4 Million in Series B Financing to Propel Precision Neuro Advancements". Geneva. 2024-01-16
BIO Deutschland e. V.. (1/11/24). "Press Release: Biotech Industry. Financing Remains Stable – Turnaround on the Horizon". Berlin. 2024-01-11
Enamine Ltd.. (1/11/24). "Press Release: Enamine and SyntheticGestalt to Collaborate on the Creation of AI-based Model to Facilitate Drug Discovery". Tokyo & Kyiv. 2024-01-11
WuXi Biologics. (1/11/24). "Press Release: WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates". Shanghai. 2024-01-11
Roche Deutschland Holding GmbH. (1/10/24). "Press Release: Prof. Hagen Pfundner wird zum 1. Mai 2024 Vorsitzender der Roche Deutschland Holding GmbH". 2024-01-10
Pierre Fabre Laboratories. (1/10/24). "Press Release: Hervé Hoppenot, Incyte CEO, Is Appointed on the Board of Pierre Fabre Laboratories". Castres. 2024-01-10
Forbion Capital Partners. (1/9/24). "Press Release: Forbion Portfolio Company Aiolos Bio, Inc. (Aiolos) to Be Acquired by GSK for up to $1.4 Billion". 2024-01-09
GSK plc. (1/9/24). "Press Release: GSK Enters Agreement to Acquire Aiolos Bio". 2024-01-09
Catalym GmbH. (1/9/24). "Press Release: Catalym Appoints Drug Development Leader Roy Baynes to its Board of Directors and Strengthens Scientific Advisory Board with Three Accomplished Lung and Bladder Cancer Specialists". Mainz. 2024-01-09
Mesenbio Ltd.. (1/9/24). "Press Release: DSW Ventures and NG Bio Lead £1.4m Investment into University of York Spinout Mesenbio". 2024-01-09
BioNTech SE. (1/9/24). "Press Release: BioNTech Outlines 2024 Strategic Priorities at the 42nd Annual J.P. Morgan Healthcare Conference". Mainz. 2024-01-09
CellPhenomics GmbH. (1/8/24). "Press Release: CellPhenomics and Charles River Announce Agreement, Expanding 3D in vitro Services for Cancer Therapy Drug Screening". Berlin & Wilmington, MA. 2024-01-08
Aion Labs. (1/8/24). "Press Release: Aion Labs Welcomes Amiti as Strategic Partner to Accelerate Israel's Position as a Leading Hub for Transformative AI-Powered Drug Discovery Innovation". Rehovot. 2024-01-08
Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. 2024-01-08
Calypso Biotech B.V.. (1/8/24). "Press Release: Calypso Enters into Agreement to Be Acquired by Novartis". Amsterdam. 2024-01-08
Shanghai Argo Biopharmaceutical Co., Ltd.. (1/7/24). "Press Release: Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis". Shanghai. 2024-01-07
CureVac N.V.. (1/5/24). "Press Release: CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform". Tübingen & Boston, MA. 2024-01-05
SanReno Therapeutics. (1/5/24). "Press Release: SanReno Therapeutics Announces Acquisition by Novartis in Pivotal Transaction to Bring Forward Transformative Therapeutics in Kidney Disease". Shanghai. 2024-01-05
Immunic, Inc.. (1/5/24). "Press Release: Immunic, Inc. Announces Private Placement of up to $240 Million". New York, NY. 2024-01-05
Sensorion S.A.. (1/5/24). "Press Release: Sensorion Announces Partnership with the Institut Pasteur to Accelerate Gene Therapy Programs Targeting Hearing Disorders Has Been Extended for Five Years". Montpellier. 2024-01-05
GlycoEra AG. (1/5/24). "Press Release: GlycoEra AG Announces New Investor, Appoints Industry Veteran Greg Fralish as Chief Business Officer". Newton, MA & Wädenswil. 2024-01-05
Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris. 2024-01-04
Menarini Group. (1/4/24). "Press Release: Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications". Florence & New York, NY. 2024-01-04
Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. 2024-01-04
Enara Bio Ltd.. (1/4/24). "Press Release: Boehringer Ingelheim Licenses Multiple Dark Antigens from Enara Bio to Develop Off-the-Shelf Immunotherapies for Non-small Cell Lung Cancer (NSCLC)". Oxford. 2024-01-04
Human Immunology Biosciences, Inc. (HI-Bio). (1/4/24). "Press Release: HI-Bio Announces $95 Million Series B Financing to Advance Targeted Therapies for Immune-Mediated Diseases". South San Francisco, CA. 2024-01-04
Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford. 2024-01-04
Full-Life Technologies. (1/4/24). "Press Release: Global Radiotherapeutics Company Full-Life Technologies Announces USD $47.3 Million Series B Financing, Prosperity7 Ventures Jointly Leads the Round". Shanghai, Gembloux & Heidelberg. 2024-01-04
Qiagen N.V.. (1/4/24). "Press Release: Qiagen to Accelerate Investments into Qiagen Digital Insights Bioinformatics Business". Venlo. 2024-01-04
ITM Isotope Technologies Munich SE. (1/4/24). "Press Release: ITM Announces Operational Readiness for NOVA Facility, the World’s Largest Lutetium-177 Production Site". Garching. 2024-01-04
Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. 2024-01-04
Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. 2024-01-03
Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. 2024-01-03
Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing". Watertown, MA. 2024-01-03
Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA. 2024-01-03
Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh. 2024-01-03
CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA. 2024-01-03
Affimed N.V.. (1/3/24). "Press Release: Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck". Mannheim. 2024-01-03
MediLink Therapeutics (Suzhou) Co., Ltd.. (1/2/24). "Press Release: MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to Develop Next-generation Antibody Drug Conjugate in Oncology". Suzhou. 2024-01-02
Apollo Therapeutics. (1/2/24). "Press Release: Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million". Cambridge & Boston, MA. 2024-01-02
Allorion Therapeutics Inc.. (1/2/24). "Press Release: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca". Natick, MA. 2024-01-02
Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel. 2023-12-29
PAI Partners SAS. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation". 2023-12-27
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/27/23). "Press Release: New Agent Regulates Serotonin Production". Berlin. 2023-12-27
Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN. 2023-12-27
AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". 2023-12-26
Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest eve 2023-12-26
Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA. 2023-12-26
Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai. 2023-12-26
Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen. 2023-12-22
Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics". Princeton, N.J. & Boston, MA. 2023-12-22
next pagenext page 1 2 3 4 ... 100 101 102  next pagenext page



Advertisement

Picture Berlin Partner BIO 2024 International Convention San Diego 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px

» top